Quantcast

Latest Amniocentesis Stories

2014-09-18 23:11:37

HRT will be showcasing its surgical amniotic product line of AmnioPro-C Flowable, AmnioPro – A Flowable, AmnioPro45™ Membrane, AmnioPro200™ Membrane and its In-Office amniotic product line to surgeons and prospective partner companies at the 2014 Annual American Orthopaedic Foot and Ankle Society Meeting (AOFAS) September 21st-23rd in Chicago. HRT continues to expand its national and international distribution network and private label opportunities with synergistic medical...

2014-09-08 16:25:56

MARIETTA, Ga., Sept. 8, 2014 /PRNewswire/ -- MiMedx Group, Inc. (NASDAQ: MDXG), an integrated developer, processor and marketer of patent protected regenerative biomaterials and bioimplants processed from human amniotic membrane, announced today that it will be hosting and webcasting its Analyst Day on Tuesday, October 14, 2014, in New York, New York. Parker H. "Pete" Petit, Chairman and CEO; William C. Taylor, President and COO; Michael J. Senken, Chief Financial Officer; and...

2014-08-04 16:25:55

MARIETTA, Ga., Aug. 4, 2014 /PRNewswire/ -- MiMedx Group, Inc. (NASDAQ: MDXG), an integrated developer, processor and marketer of patent protected regenerative biomaterials and bioimplants processed from human amniotic membrane, announced today that it will present at the 34(th) Annual Canaccord|Genuity Growth Conference in Boston, Massachusetts. Parker H. "Pete" Petit, Chairman and CEO, William C. Taylor, President and COO, and Michael J. Senken, Chief Financial Officer, are...

2014-07-15 08:29:13

MARIETTA, Ga., July 15, 2014 /PRNewswire/ -- MiMedx Group, Inc. (NASDAQ: MDXG), an integrated developer, processor and marketer of patent protected regenerative biomaterials and bioimplants processed from human amniotic membrane, announced today that its results for the second quarter, ended June 30, 2014, will be released before the opening of the market on Tuesday, July 29, 2014. MiMedx will host a live broadcast of its second quarter conference call on Tuesday, July 29, 2014, at...

2014-06-03 23:08:01

Transparency Market Research published a new report "Non-Invasive Prenatal Testing (NIPT) Market: Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2013 - 2019" to its report store. Browse the full report: http://www.transparencymarketresearch.com/noninvasive-prenatal-diagnostics-market.html. Albany, New York (PRWEB) June 03, 2014 According to a new market report published by Transparency Market Research, "Non-Invasive Prenatal Testing (NIPT) Market...

2014-05-23 08:24:51

MARIETTA, Ga., May 23, 2014 /PRNewswire/ -- MiMedx (NASDAQ: MDXG), an integrated developer, processor and marketer of patent protected regenerative biomaterials and bioimplants processed from human amniotic membrane, announced today that it will present at the Jefferies 2014 Healthcare Conference in New York, New York. Parker H. "Pete" Petit, Chairman and CEO, William C. Taylor, President and COO, and Michael J. Senken, Chief Financial Officer, are scheduled to present on Tuesday,...

2014-05-15 08:32:43

MARIETTA, Ga., May 15, 2014 /PRNewswire/ -- MiMedx (NASDAQ: MDXG), an integrated developer, processor and marketer of patent protected regenerative biomaterials and bioimplants processed from human amniotic membrane, announced today that it will present at the 11(th) Annual Craig-Hallum Institutional Investor Conference in Minneapolis, Minnesota. Parker H. "Pete" Petit, Chairman and CEO, William C. Taylor, President and COO, and Michael J. Senken, Chief Financial Officer, are...

2014-04-22 08:33:34

MARIETTA, Ga., April 22, 2014 /PRNewswire/ -- MiMedx Group, Inc. (NASDAQ: MDXG), an integrated developer, manufacturer and marketer of patent-protected regenerative biomaterials and bioimplants processed from human amniotic membrane, announced today that it has filed a patent infringement lawsuit against Liventa Bioscience, Inc. ("Liventa"), Medline Industries, Inc. ("Medline") and Musculoskeletal Transplant Foundation, Inc. ("MTF") for permanent injunctive relief and unspecified...

2014-04-21 08:25:20

MARIETTA, Ga., April 21, 2014 /PRNewswire/ -- MiMedx Group, Inc. (NASDAQ: MDXG), an integrated developer, manufacturer and marketer of patent protected regenerative biomaterials and bioimplants processed from human amniotic membrane, announced today its sponsorship of Scott Rigsby, a double-amputee athlete. As part of the relationship, Rigsby will be taking his "inspire, inform, enable" message to Boston as he returns to run the 2014 Boston Marathon on April 21. Rigsby was 18 when...

2014-04-02 16:31:06

MARIETTA, Ga., April 2, 2014 /PRNewswire/ -- MiMedx (NASDAQ: MDXG), an integrated developer, manufacturer and marketer of patent protected regenerative biomaterials and bioimplants processed from human amniotic membrane, announced today that its results for the first quarter ended March 31, 2014, will be released before the opening of the market on Friday, April 25, 2014. MiMedx will host a live broadcast of its first quarter conference call on Friday, April 25, 2014 at 10:30am EDT....


Word of the Day
cruet
  • A vial or small glass bottle, especially one for holding vinegar, oil, etc.; a caster for liquids.
This word is Middle English in origin, and ultimately comes from the Old French, diminutive of 'crue,' flask.
Related